Astrazeneca Pharmaceuticals LP
Biopharmaceutical company
Based in DE
🤖
AI Overview
With $530K in lobbying spend across 12 quarterly filings, Astrazeneca Pharmaceuticals LP is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2022 to 2025.
$530K
Total Spend
4
Years Active
1
Firms Hired
7
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $240K |
| 2023 | $50K |
| 2024 | $240K |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Health Issues, Clean Air & Water, Environment
- •COVID-19 vaccine and therapy development and deployment
- •Advising on issues related to healthcare and sustainability
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Nrx Pharmaceuticals INC (Formerly Known as Neurorx)
$754K total spend
Saliba Action Strategies (on Behalf of Islamic Relief Worldwide)
$520K total spend
Burson Cohn & Wolfe on Behalf of Astrazeneca Pharmaceuticals LP
$330K total spend
Christianacare
$53K total spend
State of Loc Nation Global Public Benefit Corporation
$160.0M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.